Dying for a cure

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

Okay, so sometimes drugs have side effects. To get the cure you’re after you may have to put up with a little dry mouth, sweaty palms, itchy scalp, even nausea. But suicide?

The BOSTON GLOBE reports that Dr. Jonathan O. Cole, a Harvard psychiatrist, is criticizing drug companies and the Food and Drug Administration for failing to take seriously the possibility that, in a small percentage of cases, antidepressants can actually lead to suicide in patients with no prior history of self-slaying thoughts. Testifying in a suit charging that the drug Zoloft caused a 13-year-old boy to kill himself, Cole said he and other researchers suggested the possible link a decade ago. So far, however, no maker of these drugs has done a serious study to confirm, deny, or measure the incidence of antidepressant-induced suicide. With more than 84 million prescriptions a year for this family of drugs, even a rare side effect can add up to significant numbers.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend